Why the study?
Pediatric hypertriglyceridemia is common and associated with acute pancreatitis and atherosclerotic cardiovascular disease, yet screening rates remain suboptimal.
This American Heart Association scientific statement provides an updated, evidence-based framework for the screening, diagnosis, and multidisciplinary management of pediatric hypertriglyceridemia.
Answers are grounded in this paper and cite their sources.
Warrants improved screening and multidisciplinary management in youth; extends consensus by identifying gaps in lifestyle and pharmacotherapy options.
Pediatric hypertriglyceridemia is common in youths, affecting 10% to 20% of US children and adolescents, and is increasingly recognized because of its association with obesity, insulin resistance, and steatotic liver disease. Hypertriglyceridemia can lead to life-threatening acute pancreatitis, and prolonged exposure may increase risk of atherosclerotic cardiovascular disease. Screening for pediatric dyslipidemia has been recommended by a number of society guidelines; however, screening rates remain suboptimal. Treatment includes a multidisciplinary approach focused on increasing physical activity, dietary interventions, and pharmacotherapy. This scientific statement outlines triglyceride metabolism and the pathophysiology of hypertriglyceridemia and provides an evidence-based review of the current literature on the screening, diagnosis and management of pediatric hypertriglyceridemia. This review highlights the need for additional research for effective lifestyle and pharmacotherapy for the treatment of pediatric hypertriglyceridemia.
No takes yet. Share an insight, caveat, or question.
Peterson et al. (2026) conducted a review in Pediatric Hypertriglyceridemia. Pediatric hypertriglyceridemia affects 10% to 20% of US youths, necessitating a multidisciplinary management approach and further research on effective lifestyle and pharmacotherapy interventions.
Synapse has enriched 10 related papers. Consider them for comparative context: